biotech stock news September 2026
Inside NurExone’s Push Into Eye and Skin Applications for Its Exosome Platform
NurExone’s exosomes are good at finding damaged tissue. Getting them past the skin’s outer barrier without breaking apart along the way is a separate problem entirely. This week the company partnered with an Israeli device maker that already has an FDA-cleared answer to exactly that problem, the same week its shareholders quietly handed the board…
Apptly’s OTCQB Listing Follows a Fresh FDA-Approved Imaging Partnership
Apptly Health Technologies signed a partnership with the maker of the only FDA-approved breast CT system on Tuesday. Two days later, on Wednesday, the company’s stock became tradable to a much larger pool of US investors for the first time. The timing wasn’t a coincidence so much as a pattern; it’s roughly the pace the…
Apptly’s OTCQB Listing Follows a Fresh FDA-Approved Imaging Partnership
Apptly Health Technologies signed a partnership with the maker of the only FDA-approved breast CT system on Tuesday. Two days later, on Wednesday, the company’s stock became tradable to a much larger pool of US investors for the first time. The timing wasn’t a coincidence so much as a pattern; it’s roughly the pace the…
